Screening for breast cancer in women who are at high risk has been shown to be more sensitive with MRI. However, a mammogram can identify some cancers that are not detected by MRI. Therefore, follow-up with mammography and MRI is recommended in these women. In the case of ovarian cancer, a clinical examination, transvaginal ultrasound, and determination of CA-125 tumor marker in blood are recommended.